Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$59,710
-$44,007 QoQ
Shares Held
381
-43.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,417
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Enhancement Trust Services, Inc. holds $26,994,149 across 12 Drug Manufacturers - General names. NVS ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
41,949 | $10,653,787 | |
| 2 | LLY |
ELI LILLY & Co
|
5,971 | $7,161,797 | |
| 3 | MRK |
Merck & Co., Inc.
|
28,812 | $3,702,341 | |
| 4 | ABBV |
AbbVie Inc.
|
9,681 | $2,436,126 | |
| 5 | AMGN |
Amgen Inc
|
5,802 | $2,101,019 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,235 | $408,709 | |
| 7 | PFE |
Pfizer Inc
|
9,430 | $227,073 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,412 | $138,978 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,710 | 381 | Shares | Defined | 2026-07-22 | |
| 2026-03-31 | $103,717 | 679 | Shares | Defined | 2026-04-08 | |
| 2025-12-31 | $103,953 | 754 | Shares | Defined | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||